Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review

被引：0
|
作者：
Nannan Li
Charlotte Beaudart
Jane A. Cauley
Steven W. Ing
Nancy E. Lane
Jean-Yves Reginster
Stuart Silverman
Andrea J. Singer
Mickaël Hiligsmann
机构：
[1] Maastricht University,Department of Health Services Research, Care and Public Health Research Institute (CAPHRI)
[2] WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging,Department of Epidemiology, School of Public Health
[3] University of Pittsburgh,Division of Endocrinology, Diabetes and Metabolism
[4] Ohio State University Wexner Medical Center,Department of Medicine
[5] University of California at Davis,Division of Public Health, Epidemiology and Health Economics
[6] School of Medicine,David Geffen School of Medicine
[7] University of Liège,Departments of Obstetrics and Gynecology and Medicine
[8] Cedars-Sinai Medical Center,undefined
[9] University of California Los Angeles,undefined
[10] MedStar Georgetown University Hospital,undefined
来源：
PharmacoEconomics | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：363 / 391
页数：28
相关论文
共 50 条
  • [1] Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
    Li, Nannan
    Beaudart, Charlotte
    Cauley, Jane A.
    Ing, Steven W.
    Lane, Nancy E.
    Reginster, Jean-Yves
    Silverman, Stuart
    Singer, Andrea J.
    Hiligsmann, Mickael
    [J]. PHARMACOECONOMICS, 2023, 41 (4) : 363 - 391
  • [2] Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
    Nannan Li
    Charlotte Beaudart
    Jane A. Cauley
    Steven W. Ing
    Nancy E. Lane
    Jean‑Yves Reginster
    Stuart Silverman
    Andrea J. Singer
    Mickaël Hiligsmann
    [J]. PharmacoEconomics, 2023, 41 : 393 - 393
  • [3] Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review (vol 41, 363, 2023)
    Li, Nannan
    Beaudart, Charlotte
    Cauley, Jane A.
    Ing, Steven W.
    Lane, Nancy E.
    Reginster, Jean-Yves
    Silverman, Stuart
    Singer, Andrea J.
    Hiligsmann, Mickael
    [J]. PHARMACOECONOMICS, 2023, 41 (04) : 393 - 393
  • [4] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Y. Wan
    F. Zeng
    H. Tan
    Y. Lu
    Y. Zhang
    L. Zhao
    R. You
    [J]. Osteoporosis International, 2022, 33 : 979 - 1015
  • [5] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Wan, Y.
    Zeng, F.
    Tan, H.
    Lu, Y.
    Zhang, Y.
    Zhao, L.
    You, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2022, 33 (05) : 979 - 1015
  • [6] A systematic review of cost‑effectiveness analyses of sequential treatment for osteoporosis
    Guangyi Yu
    Suiju Tong
    Jinyu Liu
    Yuansheng Wan
    Min Wan
    Sujuan Li
    Ruxu You
    [J]. Osteoporosis International, 2023, 34 : 641 - 658
  • [7] A systematic review of cost-effectiveness analyses of pharmacogenomic interventions
    Phillips, KA
    Van Bebber, SL
    [J]. PHARMACOGENOMICS, 2004, 5 (08) : 1139 - 1149
  • [8] An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
    Nannan Li
    Dennis Cornelissen
    Stuart Silverman
    Daniel Pinto
    Lei Si
    Ingrid Kremer
    Sandrine Bours
    Robin de Bot
    Annelies Boonen
    Silvia Evers
    Joop van den Bergh
    Jean-Yves Reginster
    Mickaël Hiligsmann
    [J]. PharmacoEconomics, 2021, 39 : 181 - 209
  • [9] A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis
    Mickaël Hiligsmann
    Silvia M. Evers
    Wafa Ben Sedrine
    John A. Kanis
    Bram Ramaekers
    Jean-Yves Reginster
    Stuart Silverman
    Caroline E. Wyers
    Annelies Boonen
    [J]. PharmacoEconomics, 2015, 33 : 205 - 224
  • [10] An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
    Li, Nannan
    Cornelissen, Dennis
    Silverman, Stuart
    Pinto, Daniel
    Si, Lei
    Kremer, Ingrid
    Bours, Sandrine
    de Bot, Robin
    Boonen, Annelies
    Evers, Silvia
    van den Bergh, Joop
    Reginster, Jean-Yves
    Hiligsmann, Mickael
    [J]. PHARMACOECONOMICS, 2021, 39 (02) : 181 - 209
12345